Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vildagliptin plus metformin versus vildagliptin plus glimepiride in adults with type 2 diabetes. The study completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vildagliptin/glimepiride (Vildagliptin/glimepiride)
  • Vildagliptin/metformin (vildagliptin/metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes, Hypoglycemia | Phase 4 | Status: COMPLETED | Results posted: 2017-07-11